,,ii #aacth ,,congress #b;d ,session ,s4 #baej ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,march #bd1 #bjad,mr4 ,blumenthal 7for himself and ,mr4 ,hatch7 introduced the following bill2 which was read twice and referred to the ,committee on the ,judiciary ,a ,,bill ,to advance the public health by encouraging independent innovators to pursue drug repurposing research and develop new treatments and cures by providing appropriate intellectual property protections for those innovations1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,independent ,innovator and ,repurposing ,act4 #b4 ,extension of patent term for method of using biological product 7a7 ,extension for regulatory delay ,the term of a patent claiming a method of using a biological product shall be extended for #e years from the original expiration date of the patent1 which shall include any patent term adjustment granted under section #aed7;b7 of title #ce1 ,united ,states ,code1 if-- 7#a7 an application for an extension is submitted by the owner of record of the patent or its agent in accordance with the requirements of subsection 7b72 and 7#b7 the term of the patent-- 7,a7 has not expired before the application is so submitted2 and 7,b7 has not been extended under subsection 7c7 of this section or section #aef of title #ce1 ,united ,states ,code4 7b7 ,application for extension ,to obtain an extension of the term of a patent under this section1 the owner of record of the patent or its agent shall submit an application to the ,director4 ,the application shall contain-- 7#a7 the identity of the biological product2 7#b7 the identity of the patent for which an extension is being sought and the identity of each claim of such patent that claims the method of using the biological product2 7#c7 information demonstrating to the ,director that-- 7,a7 the patent was issued to an independent innovator2 7,b7 the owner of record is-- 7i7 the independent innovator2 or 7ii7 a qualified small business in which the independent innovator has an ownership interest2 7,c7 an application under section #cea7;a7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bfb7;a77 for commercial marketing of the biological product for a method of use claimed in the patent has been filed2 and 7,d7 a period of not less than #aj years elapsed between the original date of submission of an application for an exemption under section #eje7;i7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7;i77 for investigating such method of use and the date on which the ,food and ,drug ,administration approved the application described in subparagraph 7,c72 and 7#d7 a brief description of the activities undertaken by the owner of record of the patent1 or the agent of such owner1 during such period with respect to the biological product and the significant dates applicable to such activities to the extent such information is possessed by such owner4 7c7 ,determination of extension 7#a7 ,in general ,a determination that a patent is eligible for extension shall be made by the ,director solely on the basis of the representations contained in the application for the extension4 ,if the ,director determines that a patent is eligible for extension under subsection 7a7 and that the requirements of subsection 7b7 have been complied with1 the ,director shall issue to the applicant for the extension of the term of the patent a certificate of extension1 under seal1 for #e years4 ,such certificate shall be recorded in the official file of the patent and shall be considered as part of the original patent4 7#b7 ,interim extension ,if the term of a patent for which an application has been submitted under subsection 7b7 would expire before a certificate of extension is issued or denied under paragraph 7#a7 respecting the application1 the ,director shall extend1 until such determination is made1 the term of the patent for periods of up to one year if the ,director determines that the patent is eligible for extension4 7d7 ,definitions ,in this section3 7#a7 ,biological product ,the term biological product has the meaning given to such term in section #cea7;i77#a7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bfb7;i77#a774 7#b7 ,director ,the term ,director means the ,under ,secretary of ,commerce for ,intellectual ,property and ,director of the ,united ,states ,patent and ,trademark ,office4 7#c7 ,independent innovator 7,a7 ,the term independent innovator means any person or entity that-- 7i7 obtains a method of use patent for a biological product2 and 7ii7 is not1 at the time of invention or patent filing1 affiliated with the holder of a marketing application approved under section #cea7;a7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bfb7;a77 for the commercial marketing of such biological product4 7,b7 ,for purposes of subparagraph 7,a7 and paragraph 7#d71 the term affiliated refers to any relationship of employment1 control1 or common ownership1 whether direct or indirect1 including through one or more intermediaries4 7#d7 ,qualified small business ,the term qualified small business means any entity with fewer than #ejj employees1 including employees of affiliates1 and which is not affiliated with the holder of the marketing application approved under section #cea7;a7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 sec4 #bfb7;a77 for the commercial marketing of such biological product4 7e7 ,effective date ,this section shall take effect on the date of the enactment of this ,act and shall apply to any unexpired patent issued before1 on1 or after that effective date4